Skip to main content

Oncology

Leukemia, Lymphoma, Oncology
Long-Term Data Support Use of Acalabrutinib in Treatment-Naïve Patients with Chronic Lymphocytic Leukemia
Chase Doyle
Chase Doyle
Read More
Multiple Myeloma, Oncology
CAR T-Cell Therapy Shows Deep, Durable Responses in Relapsed or Refractory Multiple Myeloma
Chase Doyle
Chase Doyle
Read More
Breast Cancer, Oncology
Pembrolizumab Added to First-Line Chemotherapy Improves Progression-Free Survival in Metastatic TNBC
Chase Doyle
Wayne Kuznar
Read More
Breast Cancer, Oncology
No Survival Benefit with Surgery and Radiation Added to Systemic Therapy in Patients with Newly Diagnosed Stage IV Breast Cancer
Phoebe Starr
Phoebe Starr
Read More
Lung Cancer, Oncology
Adjuvant Osimertinib a Practice-­Changing Treatment in Early-Stage NSCLC with EGFR Mutation
Wayne Kuznar
Wayne Kuznar
Read More
Lung Cancer, Oncology
Durvalumab plus Chemotherapy New Standard of Care for Extensive-Stage Small-Cell Lung Cancer
Phoebe Starr
Phoebe Starr
Read More
Lung Cancer, Oncology
Capmatinib Shows Activity in MET-Amplified Non–Small-Cell Lung Cancer
Wayne Kuznar
Wayne Kuznar
Read More
Leukemia, Lymphoma, Oncology
Axicabtagene Ciloleucel Induces Durable Responses in Advanced Follicular and Marginal-Zone Lymphoma
Wayne Kuznar
Wayne Kuznar
Read More
Leukemia, Lymphoma, Oncology
CAR T-Cell Therapy Shows Highly Durable Remissions in CLL and B-Cell Lymphoma
Chase Doyle
Chase Doyle
Read More
FDA Approvals, Lung Cancer, Oncology
FDA Approves Cyramza plus Tarceva for First-Line Treatment of Metastatic NSCLC with EGFR Mutation
Read More
Page 5 of 27
Results 41 - 50 of 262